Clinical Trial

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

Study acronym: SHIELD
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-05-07; most recent amendment 2026-03-06.
Status change: Recruiting → Active, Not Recruiting 2024-10-04
Trial Details
NCT Number NCT06411418
Lead Sponsor Jacobs institute
Conditions Intracranial Aneurysms
Enrollment 10 participants
Start Date 2023-09-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-10